Future trends in the treatment of non-alcoholic steatohepatitis

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Stefano FiorucciEleonora Distrutti

Abstract

With an estimated prevalence of ≈25% in Western and Asian countries, non alcoholic fatty liver disease (NAFLD), caused by chronic excessive caloric intake, is the emerging as the most prevalent liver disorder worldwide. NAFLD exists in two clinical entities, non-alcoholic fatty liver disease (NAFL), a relative benign disease that carry on minimal risk of liver-related morbidity but significant risk of cardiovascular complications, and non-alcoholic steatohepatitis (NASH), a progressive liver disorder with a significant risk for development of liver-related morbidities and mortality. While, liver injury in NASH is contributed by lipid overload in hepatocytes, lipotoxicity, the main determinant of disease progression is an inflammation-driven fibrotic response. Here, we review the landscape of emerging pharmacological interventions in the treatment of NAFL and NASH. A consensus exists that, while treating the liver component of NASH requires development of novel pharmacological approaches, the future therapy of NASH needs to be tailored to the single patient and most likely will be a combination of agents acting on specific pathogenic mechanisms at different disease stage.

Citations

Nov 10, 2018·Expert Opinion on Pharmacotherapy·Yuji OgawaAtsushi Nakajima
Nov 13, 2018·Transplantation·Ivan LinaresMarkus Selzner
Jun 20, 2020·Expert Opinion on Investigational Drugs·Stefano FiorucciEleonora Distrutti
Mar 5, 2019·Metabolomics : Official Journal of the Metabolomic Society·Da Jung KimJoo-Youn Cho
Jun 10, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Micah Grubert Van IderstineGerald Y Minuk
Jun 27, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Ruth C R MeexLuc J C van Loon
Nov 25, 2019·Internal Medicine Journal·Tony Dazhong HuangAmany Zekry
Jul 22, 2019·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Adriana CarinoStefano Fiorucci
Dec 29, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Adriana CarinoStefano Fiorucci
Feb 27, 2021·Progress in Lipid Research·Stefano FiorucciMichele Biagioli
Jun 12, 2020·Cellular and Molecular Gastroenterology and Hepatology·Trenton T RossWilliam P Esler
Jan 19, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Waleska Dornas, Vincent Lagente
Dec 5, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Silvia MarchianòStefano Fiorucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here